{
    "code": "02009147",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02009147",
    "time": "2021-04-09 03:11:21",
    "許可證字號": "衛署藥輸字第009147號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/09\/08",
    "發證日期": "102\/04\/29",
    "許可證種類": "製　劑",
    "舊證字號": "02007567",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200914703",
    "中文品名": "移護寧５０毫克錠",
    "英文品名": "IMURAN AZATHIOPRINE TABLETS 50MG B.P.",
    "適應症": "腎臟移植手術防止排斥作用的輔助療法、全身性紅斑狼瘡、重度風濕性關節炎、急慢性白血病",
    "劑型": "116膜衣錠",
    "包裝": "100粒盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "AZATHIOPRINE",
    "限制項目": "02輸　入",
    "申請商名稱": "6401022326  安沛國際有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號20樓",
    "主製造廠": [
        {
            "製造廠名稱": "FZA0026000  ASPEN PORT ELIZABETH (PTY.) LTD. UNIT4",
            "製造廠廠址": "CORNER OF FAIRCLOUGH AND GIBAUD ROADS, KORSTEN, PORT ELIZABETH, 6020, REPUBLIC OF SOUTH AFRICA",
            "製造廠公司地址": "",
            "製造廠國別": "SOUTH AFRICA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FMU0001000  ASPEN GLOBAL INCORPORATED",
            "製造廠廠址": "GBS PLAZA, CNR LA SALETTE AND ROYAL ROADS, GRAND BAY, MAURITIUS",
            "製造廠公司地址": "",
            "製造廠國別": "MAURITUS",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008800100",
            "成分名稱": "AZATHIOPRINE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "yellow tablet, biconvex, scored and branded IM 5",
        "特殊劑型": "",
        "顏色": "淺黃色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "圓凸形",
        "標記一": "IM 5",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "IMURAN FCT 50 mg (APE)-110-01-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=421&Type=10"
        },
        {
            "title": "Imuran FCT 50mg_Foil_562669-109-07-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=420&Type=10"
        },
        {
            "title": "Imuran tab-106-07-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=419&Type=10"
        },
        {
            "title": "02009147.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=418&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Imuran FCT 50mg_PIL_576546-109-07-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=011&Type=9"
        },
        {
            "title": "中文仿單_Imuran tab_AZA-1905-01 CCDS v24-108-06-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=010&Type=9"
        },
        {
            "title": "Imuran FCT 50mg_CTN_547219-109-07-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009147&Seq=001&Type=8"
        }
    ]
}